FI935110L - N,N-disubstituerade arylcykloalkylaminer, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning samt foerfarande foer deras framstaellning - Google Patents

N,N-disubstituerade arylcykloalkylaminer, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning samt foerfarande foer deras framstaellning Download PDF

Info

Publication number
FI935110L
FI935110L FI935110A FI935110A FI935110L FI 935110 L FI935110 L FI 935110L FI 935110 A FI935110 A FI 935110A FI 935110 A FI935110 A FI 935110A FI 935110 L FI935110 L FI 935110L
Authority
FI
Finland
Prior art keywords
deras
disubstituerade
arylcykloalkylaminer
salter
framstaellning
Prior art date
Application number
FI935110A
Other languages
English (en)
Finnish (fi)
Other versions
FI935110A7 (fi
FI935110A0 (fi
Inventor
Roland Maier
Peter Mueller
Eberhard Woitun
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Ralph-Michael Budzinski
Gerhard Hallermayer
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI935110A0 publication Critical patent/FI935110A0/fi
Publication of FI935110A7 publication Critical patent/FI935110A7/fi
Publication of FI935110L publication Critical patent/FI935110L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/79—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
FI935110A 1992-11-20 1993-11-18 N,N-disubstituerade arylcykloalkylaminer, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning samt foerfarande foer deras framstaellning FI935110L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4239151A DE4239151A1 (de) 1992-11-20 1992-11-20 N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
FI935110A0 FI935110A0 (fi) 1993-11-18
FI935110A7 FI935110A7 (fi) 1994-05-21
FI935110L true FI935110L (fi) 1994-05-21

Family

ID=6473324

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935110A FI935110L (fi) 1992-11-20 1993-11-18 N,N-disubstituerade arylcykloalkylaminer, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning samt foerfarande foer deras framstaellning

Country Status (19)

Country Link
US (1) US5455273A (OSRAM)
EP (1) EP0599203A1 (OSRAM)
JP (1) JPH06211763A (OSRAM)
KR (1) KR940011435A (OSRAM)
CN (1) CN1093082A (OSRAM)
AU (1) AU665281B2 (OSRAM)
CA (1) CA2103381A1 (OSRAM)
CZ (1) CZ248593A3 (OSRAM)
DE (1) DE4239151A1 (OSRAM)
FI (1) FI935110L (OSRAM)
HU (1) HU211996B (OSRAM)
IL (1) IL107653A0 (OSRAM)
MX (1) MX9307232A (OSRAM)
NO (1) NO934196L (OSRAM)
NZ (1) NZ250230A (OSRAM)
PL (1) PL301101A1 (OSRAM)
SK (1) SK123993A3 (OSRAM)
TW (1) TW252097B (OSRAM)
ZA (1) ZA938647B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US5962507A (en) * 1994-04-25 1999-10-05 Dr. Karl Thomae Gmbh O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds, and their use, as well as a method of preparing them
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
ES2352739T3 (es) 1997-11-21 2011-02-22 Purdue Neuroscience Company 2-aminoacetamidas sustituidas y el uso de las mismas.
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US6410521B1 (en) * 1998-06-12 2002-06-25 Osteoscreen, Inc. Nutritional supplements for stimulating bone growth
BR0111267A (pt) * 2000-06-06 2003-12-16 Warner Lambert Co Cicloexilaminas bicìclicas e seu uso como antagonistas do receptor de nmda
WO2002014267A1 (en) * 2000-08-16 2002-02-21 F. Hoffmann-La Roche Ag Novel aminocyclohexane derivatives
EP1456171B1 (en) * 2001-12-12 2006-12-20 F. Hoffmann-La Roche Ag Substituted cyclohexane derivatives
US7012077B2 (en) 2001-12-20 2006-03-14 Hoffmann-La Roche Inc. Substituted cyclohexane derivatives
US20040122105A1 (en) * 2002-09-20 2004-06-24 Griscom Bettle Transdermal compositions
TW200808695A (en) * 2006-06-08 2008-02-16 Amgen Inc Benzamide derivatives and uses related thereto
KR101420730B1 (ko) 2007-10-31 2014-07-18 삼성전자주식회사 영상기기 및 그의 영상신호 수신방법
JP5453165B2 (ja) * 2010-05-13 2014-03-26 信越化学工業株式会社 アルデヒド及びケトンの製造方法
RU2016149812A (ru) 2014-06-06 2018-07-17 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
MX2017005462A (es) 2014-11-05 2017-07-28 Flexus Biosciences Inc Agentes inmunorreguladores.
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
JP2019516681A (ja) * 2016-05-04 2019-06-20 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company インドールアミン2,3−ジオキシゲナーゼ阻害剤およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979444A (en) * 1974-05-28 1976-09-07 The Upjohn Company 4-Arylcyclohexylamines
US4886929A (en) * 1987-06-15 1989-12-12 Uop Inc. Separation of para-xylene
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives

Also Published As

Publication number Publication date
US5455273A (en) 1995-10-03
TW252097B (OSRAM) 1995-07-21
MX9307232A (es) 1994-07-29
CA2103381A1 (en) 1994-05-21
ZA938647B (en) 1995-05-19
FI935110A7 (fi) 1994-05-21
HU211996B (en) 1996-01-29
CZ248593A3 (en) 1994-06-15
NO934196L (no) 1994-05-24
EP0599203A1 (de) 1994-06-01
NO934196D0 (no) 1993-11-19
HUT65760A (en) 1994-07-28
AU665281B2 (en) 1995-12-21
DE4239151A1 (de) 1994-05-26
KR940011435A (ko) 1994-06-21
IL107653A0 (en) 1994-02-27
PL301101A1 (en) 1994-06-27
AU5182593A (en) 1994-06-02
JPH06211763A (ja) 1994-08-02
CN1093082A (zh) 1994-10-05
HU9303298D0 (en) 1994-03-28
FI935110A0 (fi) 1993-11-18
SK123993A3 (en) 1994-09-07
NZ250230A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
FI934460A7 (fi) Karboxylsyraderivat, laekemedel innehaollande dessa foereningar samt foerfaranden foer deras framstaellning
FI933857A7 (fi) Kondenserade heterocykliska foereningar, deras framstaellning och anvaendning
FI934274L (fi) N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI931608L (fi) Foerfarande och anordning foer terapeutisk, elektromagnetisk behandling
FI931901L (fi) Azolfoereningar, deras framstaellning och anvaendning
FI931305A7 (fi) Imidazolfoereningar, deras framstaellning och bruk
FI935920L (fi) Oxazolinderivat och deras farmaceutiskt godtagbara salter
FI933942L (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI930620A0 (fi) Bensimidazolylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI930270L (fi) Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner
FI931190A7 (fi) Triazolopyridazinfoereningar, deras framstaellning och anvaendning
FI934711L (fi) Stabiliserad sorbinsyra och salter daerav
FI930711L (fi) Naftalenderivat, foerfarande foer deras framstaellning och deras syntetiska mellanprodukter
FI932649L (fi) Bifenylderivat, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
FI930977L (fi) Taxanderivat, deras framstaellning och onkologiska anvaendning
FI930051L (fi) 4,13-dioxabicyklo(8.2.1)tridecenonderivat samt foerfarande och mellanprodukt foer deras framstaellning
FI922004A0 (fi) Maetningsfoerfarande och maetanordning.
FI931414L (fi) Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi
FI931599L (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
FI934221A0 (fi) Piperidinderivat, framstaellning och terapeutisk anvaendning daerav
FI931682A0 (fi) Tackykininreceptorantagonister, isokinoloner och deras framstaellning
FI930236L (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
FI931881L (fi) Maerkta fibrinogen-resepto-antagonister, deras anvaendning och foerfarande foer deras framstaellning
FI934665L (fi) Aryliden-1-azacykloalkaner och arylalkyl-1-azacyckloalkaner, deras salter, dessa foereningar innehaollande laekemedel och deras anvaendning och framstaellning
FI935132L (fi) Fenolisk resolfanerharts, foerfarande och tillverkning

Legal Events

Date Code Title Description
FD Application lapsed